FolioLanternBeta
WGSGeneDx Holdings Corp.

Katherine Stueland

Chief Executive Officer, Director at GeneDx Holdings Corp., as of Sep 18, 2026Sold $11.5M of stock in the past 12 months: 100% to cover taxes.

Updated Oct 15, 2026 from SEC filings · covers Oct 16, 2025 to Oct 15, 2026
115K
shares held after the latest filing, GeneDx Holdings Corp.
Vested shares reported on Forms 3, 4 and 5 only. Not the insider's whole wealth.
142K
shares sold, past 12 months
13
days with sales
$3.0M
largest single day, Mar 26, 2026
1
company filed for

Share of stake sold at GeneDx Holdings Corp. is not shown: most of their shares vested during the period, so a percentage would mislead. Why

Selling by month

Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.

To cover taxesOne dollar scale for every month; the tallest bar is labeled
Oct 2025: $295K to cover taxesOctNovDec 2025: $2.1M to cover taxesDecJan 2026: $155K to cover taxesJanFebMar 2026: $6.6M to cover taxes$6.6MMarApr 2026: $142K to cover taxesAprMayJun 2026: $834K to cover taxesJunJulAugSep 2026: $1.3M to cover taxesSepOct

Pattern

What the filings show, past 12 months. Nothing here rates or predicts.

Roles from filings

Every company we track where this person has filed, newest filing first.

CompanyTitleFirst filingLatest filing
GeneDx Holdings Corp. (WGS)Chief Executive Officer, DirectorMay 4, 2022Sep 18, 2026

Recent filings

The last 5 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.

This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.